Desem N - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS.

Limmroth V, Barkhof F, Desem N, Diamond MP, Tachas G; ATL1102 Study Group. Limmroth V, et al. Among authors: desem n. Neurology. 2014 Nov 11;83(20):1780-8. doi: 10.1212/WNL.0000000000000926. Epub 2014 Sep 19. Neurology. 2014. PMID: 25239835 Free PMC article. Clinical Trial.

EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial.

Rice ASC, Dworkin RH, McCarthy TD, Anand P, Bountra C, McCloud PI, Hill J, Cutter G, Kitson G, Desem N, Raff M; EMA401-003 study group. Rice ASC, et al. Among authors: desem n. Lancet. 2014 May 10;383(9929):1637-1647. doi: 10.1016/S0140-6736(13)62337-5. Epub 2014 Feb 5. Lancet. 2014. PMID: 24507377 Clinical Trial.

Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection.

Streeton JA, Desem N, Jones SL. Streeton JA, et al. Among authors: desem n. Int J Tuberc Lung Dis. 1998 Jun;2(6):443-50. Int J Tuberc Lung Dis. 1998. PMID: 9626600

Development of a human gamma interferon enzyme immunoassay and comparison with tuberculin skin testing for detection of Mycobacterium tuberculosis infection.

Desem N, Jones SL. Desem N, et al. Clin Diagn Lab Immunol. 1998 Jul;5(4):531-6. doi: 10.1128/CDLI.5.4.531-536.1998. Clin Diagn Lab Immunol. 1998. PMID: 9665962 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results